Breaking News

You are here » Indian-Commodity  :  Top News  :  Lasa Supergenerics commences trial production run in Unit IV at Chiplun


Lasa Supergenerics commences trial production run in Unit IV at Chiplun

Lasa Supergenerics has commenced the trial production at Unit IV, situated at Chiplun in state of Maharashtra. The Unit IV was earlier known as Unit V. The regular production will be subject to success of the trial runs. The company is geared up to take advantage of this significant opportunity and expand in lines with strategic plans.

The planned production and capacity per annum includes Albendazole Intermediate (400 MT), Fenbendazole Intermediate (200 MT), 2 4 DCP (600 MT), Closantel Intermediate (100 MT) and additionally a few components of backward integration for its recent new launches.

Lasa Supergenerics manufactures and distributes chemicals. The company offers veterinary API products, animal feed ingredients, and reagents for therapeutic uses.

Related News

View all news

Gold futures decline on firming dollar

Gold futures declined on MCX as traders await the minutes from the US Federal Reserve's latest policy meeting for fresh clues on the pace of interest rate hikes. Besides, a firming dollar against some......

Coriander futures edge higher on improved demand

Coriander futures edged higher on NCDEX as participants built up fresh positions on the back of improved demand at the spot market. Further, tight supplies from major producing regions also fuelled the......

Gold end higher on Tuesday

Gold futures ended higher on Tuesday amid weak dollar against basket of major currencies, ahead of the release of minutes of Federal Open Market Committee's September meeting. Gold futures for December......

Top News

View all news

Hero MotoCorp achieves best ever sales performance in Q2 FY19

Hero MotoCorp has achieved its best-ever sales performance for the second quarter of any financial year, selling 21,34,051 units of two-wheelers in Q2 FY19.For the period April-September 2018, Hero MotoCorp......

Mahindra CIE Automotive reports 74% rise in Q3 net profit

Mahindra CIE Automotive has reported results for third quarter ended September 30, 2018.The company has reported 73.80% rise in its net profit at Rs 42.58 crore for the quarter under review as compared......

Infosys crosses $2 billion large deal signings in Q2 FY19

Infosys has crossed $2 billion large deal signings in Q2 FY19. Besides, the company's digital revenues stood at $905 million in Q2 FY19 (31.0% of total revenues), year-on-year growth of 33.5% and sequential......